vimarsana.com

Page 8 - சோனா நானோடெக் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Sona Nanotech Inc

Share this article Share this article NEW YORK, Dec. 17, 2020 /PRNewswire/  Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Sona Nanotech Inc. (OTC: SNANF) between July 2, 2020 and November 25, 2020, inclusive (the Class Period ). The lawsuit seeks to recover damages for Sona investors under the federal securities laws. To join the Sona class action, go http://www.rosenlegal.com/cases-register-1994.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) it was unreasonable for Sona to represent that it could receive results from field studies of its COVID-19 antigen test within a month;  (2) Sona s positive statements about its COVID-19 antigen test were

Sona Nanotech Inc : Sona Nanotech Closes Unbrokered Private Placement Financing for $2 26M in Gross Proceeds

Sona Nanotech Inc.: Sona Nanotech Closes Unbrokered Private Placement Financing for $2.26M in Gross Proceeds Halifax, Nova Scotia (Newsfile Corp. - December 16, 2020) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the Company , Sona ) a developer of rapid, point-of-care diagnostic tests, is pleased to announce that it has closed its non-brokered private placement that was announced on December 3, 2020 with the issuance of 2,259,200 units at $1.00 per unit. The final amount of the offering represents an increase from the Company s previously announced intention to raise up to $2,000,000 through a non-brokered private placement (the Financing ) of up to 2,000,000 units of Sona (each, a Unit ) at $1.00 per Unit due to investor interest. Each Unit consists of one common share of Sona (a Common Share ) and one-half of a Common Share purchase warrant (each whole Common Share purchase warrant, a Warrant ). Each Warrant is exercisable to purchase one additional Common Share of So

Sona Nanotech Closes Unbrokered Private Placement Financing for $2 26M in Gross Proceeds

Sona Nanotech Closes Unbrokered Private Placement Financing for $2.26M in Gross Proceeds Sona Nanotech Inc. a developer of rapid, point-of-care diagnostic tests, is pleased to announce that it has closed its non-brokered private placement that was announced on December 3, 2020 with the issuance of 2,259,200 units at $1.00 per unit.The final amount of the offering represents an increase from the Company’s previously announced intention to raise up to $2,000,000 through a non-brokered private placement of … Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”, “Sona”) a developer of rapid, point-of-care diagnostic tests, is pleased to announce that it has closed its non-brokered private placement that was announced on December 3, 2020 with the issuance of 2,259,200 units at $1.00 per unit.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.